Anika Therapeutics (ANIK) Exchange Rate Effect (2010 - 2026)
Anika Therapeutics (ANIK) reported Exchange Rate Effect of -$29000.0 for Q1 2026, down 126.85% year-over-year from $108000.0 in Q1 2025, and up 55.38% quarter-over-quarter from -$65000.0 in Q4 2025.
Anika Therapeutics (ANIK) Exchange Rate Effect (2010 - 2026) Analysis & Trends
Anika Therapeutics (ANIK) has 17 years of Exchange Rate Effect data on file, last reported at -$29000.0 in Q1 2026.
- Exchange Rate Effect for Q1 2026 came in at -$29000.0, down 126.85% year-over-year; the trailing twelve-month figure through Mar 2026 was -$51000.0 (down 156.04% YoY), and the FY2025 annual result was $86000.0, up 279.17% from the prior year.
- Exchange Rate Effect advanced to -$29000.0 in Q1 2026 per ANIK's latest filing, from -$65000.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $345000.0 in Q2 2025 and troughed at -$302000.0 in Q3 2025.
- A 5-year average of -$2470.6 and a median of -$29000.0 in 2026 frame the typical range for Exchange Rate Effect.
- The sharpest annual moves came in 2023 and 2024: Exchange Rate Effect soared 850.0% in 2023, then slumped 929.63% in 2024.
- A 5-year view of Exchange Rate Effect shows it stood at -$69000.0 in 2022, then jumped by 210.14% to $76000.0 in 2023, then sank by 271.05% to -$130000.0 in 2024, then soared by 50.0% to -$65000.0 in 2025, then surged by 55.38% to -$29000.0 in 2026.
- Business Quant data shows ANIK's Exchange Rate Effect at -$29000.0 in Q1 2026, -$65000.0 in Q4 2025, and -$302000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -17.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 17.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -5.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -2.38 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -22,000.00 |
| 10 | Anika Therapeutics | 197.89 Mn | 131.10 Mn | 19.00 Mn | -29,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29,000.00 |
| Mar 31, 2026 | -29,000.00 |
| Dec 31, 2025 | -65,000.00 |
| Dec 31, 2025 | -65,000.00 |
| Sep 30, 2025 | -302,000.00 |
| Sep 30, 2025 | -302,000.00 |
| Jun 30, 2025 | 345,000.00 |
| Jun 30, 2025 | 345,000.00 |
| Mar 31, 2025 | 108,000.00 |
| Mar 31, 2025 | 108,000.00 |
| Dec 31, 2024 | -130,000.00 |
| Dec 31, 2024 | -130,000.00 |
| Sep 30, 2024 | 337,000.00 |
| Sep 30, 2024 | 337,000.00 |
| Jun 30, 2024 | -224,000.00 |
| Jun 30, 2024 | -224,000.00 |
| Mar 31, 2024 | -31,000.00 |
| Mar 31, 2024 | -31,000.00 |
| Dec 31, 2023 | 76,000.00 |
| Dec 31, 2023 | 76,000.00 |